Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

K Harte

Showing results (1-10 of 42) with videos related to

Pageof 5
Sort By:
Biochemical Society Transactions|March 21, 2007
The neuronal pathology of schizophrenia: molecules and mechanismsG P Reynolds, M K Harte
Journal of Anxiety Disorders|April 29, 1998
Children's self-talk under conditions of mild anxietyJ Lodge, D K Harte, G Tripp
Medical Education|March 7, 2002
The implementation of Tomorrow's DoctorsD F Christopher, K Harte, C F George
Neuroscience Letters|January 26, 2010
Effect of subchronic phencyclidine administration on sucrose preference and hippocampal parvalbumin immunoreactivity in the ratTrisha A Jenkins, Michael K Harte, Gavin P Reynolds
Schizophrenia Research|May 12, 2005
Increased N-acetylaspartate in rat striatum following long-term administration of haloperidolM K Harte, S B Bachus, G P Reynolds
Behavioural Brain Research|July 28, 2009
Neonatal lipopolysaccharide induces pathological changes in parvalbumin immunoreactivity in the hippocampus of the ratTrisha A Jenkins, Michael K Harte, Gillian Stenson, et al.
Journal of Psychopharmacology (Oxford, England)|October 4, 2019
Synaptic biomarker reduction and impaired cognition in the sub-chronic PCP mouse model for schizophreniaJohn Gigg, Francesca McEwan, Rebecca Smausz, et al.
Journal of Psychopharmacology (Oxford, England)|April 27, 2017
Dopamine dysregulation in the prefrontal cortex relates to cognitive deficits in the sub-chronic PCP-model for schizophrenia: A preliminary investigationSamantha L McLean, Michael K Harte, Joanna C Neill, et al.
Pharmacology Research & Perspectives|April 3, 2021
In vivo effects of AZD4547, a novel fibroblast growth factor receptor inhibitor, in a mouse model of endometriosisSara Santorelli, Deborah P Fischer, Michael K Harte, et al.
Journal of Neural Transmission. Supplementum|November 7, 2007
Deficits of neuronal glutamatergic markers in the caudate nucleus in schizophreniaS Nudmamud-Thanoi, P Piyabhan, M K Harte, et al.
Pageof 5

Showing results (1-10 of 42) with videos related to

Sort By:
Pageof 5
Biochemical Society Transactions|March 21, 2007
The neuronal pathology of schizophrenia: molecules and mechanismsG P Reynolds, M K Harte
Journal of Anxiety Disorders|April 29, 1998
Children's self-talk under conditions of mild anxietyJ Lodge, D K Harte, G Tripp
Medical Education|March 7, 2002
The implementation of Tomorrow's DoctorsD F Christopher, K Harte, C F George
Neuroscience Letters|January 26, 2010
Effect of subchronic phencyclidine administration on sucrose preference and hippocampal parvalbumin immunoreactivity in the ratTrisha A Jenkins, Michael K Harte, Gavin P Reynolds
Schizophrenia Research|May 12, 2005
Increased N-acetylaspartate in rat striatum following long-term administration of haloperidolM K Harte, S B Bachus, G P Reynolds
Behavioural Brain Research|July 28, 2009
Neonatal lipopolysaccharide induces pathological changes in parvalbumin immunoreactivity in the hippocampus of the ratTrisha A Jenkins, Michael K Harte, Gillian Stenson, et al.
Journal of Psychopharmacology (Oxford, England)|October 4, 2019
Synaptic biomarker reduction and impaired cognition in the sub-chronic PCP mouse model for schizophreniaJohn Gigg, Francesca McEwan, Rebecca Smausz, et al.
Journal of Psychopharmacology (Oxford, England)|April 27, 2017
Dopamine dysregulation in the prefrontal cortex relates to cognitive deficits in the sub-chronic PCP-model for schizophrenia: A preliminary investigationSamantha L McLean, Michael K Harte, Joanna C Neill, et al.
Pharmacology Research & Perspectives|April 3, 2021
In vivo effects of AZD4547, a novel fibroblast growth factor receptor inhibitor, in a mouse model of endometriosisSara Santorelli, Deborah P Fischer, Michael K Harte, et al.
Journal of Neural Transmission. Supplementum|November 7, 2007
Deficits of neuronal glutamatergic markers in the caudate nucleus in schizophreniaS Nudmamud-Thanoi, P Piyabhan, M K Harte, et al.
Pageof 5